Epidermal Growth Factor Receptor Mutation Status and Response to Tyrosine Kinase Inhibitors in Advanced Chinese Female Lung Squamous Cell Carcinoma: A Retrospective Study

BACKGROUND: The frequency of epidermal growth factor receptor (EGFR) mutations and the efficacy of tyrosine kinase inhibitor (TKI) in Chinese female patients with lung squamous cell carcinoma (SCC) are unknown. This study was designed to investigate the incidence of EGFR mutations and the role of ta...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Qing, Qiang, Huiping, Qian, Jialin, Lei, Yuqiong, Lu, Jiahuan, Feng, Hui, Zhao, Yiming, Han, Baohui, Zhang, Yanwei, Chu, Tianqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050333/
https://www.ncbi.nlm.nih.gov/pubmed/33869057
http://dx.doi.org/10.3389/fonc.2021.652560

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050333/
https://www.ncbi.nlm.nih.gov/pubmed/33869057
http://dx.doi.org/10.3389/fonc.2021.652560

Ejemplares similares